Literature DB >> 7526379

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

J B Sun1, J Holmgren, C Czerkinsky.   

Abstract

Oral administration of antigens, including allergens and autoantigens, may be an efficient way to prevent diseases associated with untoward immune responses to self- and non-self-antigens. However, this approach has met with limitations because it usually requires repeated administrations of large doses of antigen and is less efficient in an already immune host, and the effect is of short duration. We report that a single oral administration of minute amounts of particulate or soluble antigen coupled to the B subunit of cholera toxin (CTB) can markedly suppress systemic immune responses in naive and in systemically immune animals. Both early (2-4 hr) and late (24-48 hr) delayed type-hypersensitivity reactivities were strongly suppressed after feeding a single dose of CTB-conjugated antigen. Serum antibody responses were also decreased, although moderately, after oral administration of CTB-conjugated antigen. This strategy of tolerance induction, based on oral administration of small amounts of antigens conjugated to a mucosa-binding molecule, may find broad applications for preventing or abrogating untoward immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526379      PMCID: PMC45112          DOI: 10.1073/pnas.91.23.10795

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Could specific oral tolerance be a therapy for autoimmune disease?

Authors:  H S Thompson; N A Staines
Journal:  Immunol Today       Date:  1990-11

2.  Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen.

Authors:  C André; H Bazin; J F Heremans
Journal:  Digestion       Date:  1973       Impact factor: 3.216

3.  The induction of tolerance to a soluble protein antigen by oral administration.

Authors:  H C Thomas; M V Parrott
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

Review 4.  Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems.

Authors:  J Holmgren; N Lycke; C Czerkinsky
Journal:  Vaccine       Date:  1993-09       Impact factor: 3.641

5.  Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.

Authors:  Z Y Wang; J Qiao; H Link
Journal:  J Neuroimmunol       Date:  1993-05       Impact factor: 3.478

6.  Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.

Authors:  Z Y Zhang; C S Lee; O Lider; H L Weiner
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

7.  Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

Authors:  H L Weiner; G A Mackin; M Matsui; E J Orav; S J Khoury; D M Dawson; D A Hafler
Journal:  Science       Date:  1993-02-26       Impact factor: 47.728

8.  Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines.

Authors:  M Lebens; S Johansson; J Osek; M Lindblad; J Holmgren
Journal:  Biotechnology (N Y)       Date:  1993-12

9.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  Z J Zhang; L Davidson; G Eisenbarth; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

View more
  74 in total

1.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

Authors:  A George-Chandy; K Eriksson; M Lebens; I Nordström; E Schön; J Holmgren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.

Authors:  C Aspord; C Thivolet
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

4.  Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.

Authors:  Sung-Ung Moon; Hyung-Hwan Kim; Tong-Soo Kim; Kyung-Mi Choi; Chang-Mi Oh; Yong-Joo Ahn; Seo-Kyoung Hwang; Youngjoo Sohn; E-Hyun Shin; Hyuck Kim; Hyeong-Woo Lee
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

5.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Cholera toxin induces a transient depletion of CD8+ intraepithelial lymphocytes in the rat small intestine as detected by microarray and immunohistochemistry.

Authors:  Carl-Fredrik Flach; Stefan Lange; Eva Jennische; Ivar Lönnroth; Jan Holmgren
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice.

Authors:  Tae-Geum Kim; Jie Yu; John Hough; David Henderson; William H R Langridge
Journal:  Mol Biotechnol       Date:  2005-07       Impact factor: 2.695

8.  Recent advances in immunotherapy of allergic rhinitis.

Authors:  Chul Hee Lee; Ji-Hun Mo
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

9.  Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.

Authors:  Tae-Geum Kim; Nguyen-Xuan Huy; Mi-Young Kim; Dong-Keun Jeong; Yong-Suk Jang; Moon-Sik Yang; William H R Langridge; Jin-Yong Lee
Journal:  Mol Biotechnol       Date:  2008-09-20       Impact factor: 2.695

10.  Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.

Authors:  Mi-Young Kim; Byeong-Young Kim; Sun-Mi Oh; Rajko Reljic; Yong-Suk Jang; Moon-Sik Yang
Journal:  Plant Mol Biol       Date:  2016-08-26       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.